Jiangsu Jibeier Pharmaceutical Co Ltd (688566) - Total Liabilities

Latest as of September 2025: CN¥269.87 Million CNY ≈ $39.49 Million USD

Based on the latest financial reports, Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has total liabilities worth CN¥269.87 Million CNY (≈ $39.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688566 cash generation efficiency to assess how effectively this company generates cash.

Jiangsu Jibeier Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Jiangsu Jibeier Pharmaceutical Co Ltd to evaluate the company's liquid asset resilience ratio.

Jiangsu Jibeier Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Jibeier Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
PPHE Hotel Group Ltd F:32P	Germany	€1.40 Billion
Banco Mercantil do Brasil S.A SA:BMEB3	Brazil	R$29.22 Billion
BANPU POWER BK:BPP-R	Thailand	฿42.69 Billion
MLP SE XETRA:MLP	Germany	€3.56 Billion
Aeva Technologies, Inc. Common Stock NASDAQ:AEVA	USA	$166.49 Million
Lotus Technology Inc. NASDAQ:LOT	USA	$3.12 Billion
Indus Holding AG XETRA:INH	Germany	€1.20 Billion
Shenzhen Prince New Materials Co Ltd SHE:002735	China	CN¥1.40 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Jiangsu Jibeier Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Jiangsu Jibeier Pharmaceutical Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	7.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.11	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.10	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Jibeier Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Jiangsu Jibeier Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥273.68 Million ≈ $40.05 Million	-8.55%
2023-12-31	CN¥299.25 Million ≈ $43.79 Million	+10.73%
2022-12-31	CN¥270.24 Million ≈ $39.55 Million	+28.45%
2021-12-31	CN¥210.40 Million ≈ $30.79 Million	+23.10%
2020-12-31	CN¥170.92 Million ≈ $25.01 Million	+36.56%
2019-12-31	CN¥125.16 Million ≈ $18.31 Million	+4.02%
2018-12-31	CN¥120.32 Million ≈ $17.61 Million	+38.43%
2017-12-31	CN¥86.92 Million ≈ $12.72 Million	-26.96%
2016-12-31	CN¥118.99 Million ≈ $17.41 Million	--

About Jiangsu Jibeier Pharmaceutical Co Ltd

SHG:688566 China Drug Manufacturers - Specialty & Generic

Market Cap

$821.50 Million

CN¥5.61 Billion CNY

Market Cap Rank

#10084 Global

#2878 in China

Share Price

CN¥28.15

Change (1 day)

+0.54%

52-Week Range

CN¥24.05 - CN¥42.20

All Time High

CN¥51.60